
Healthcare and Biotech Stocks Cruise Along with 9% Gains in One Month
The XLV gains 9.2% over past month in a broad rally led by Biopharma and MedTech: examples REGN, GEHC, LLY, BDX, GILD etc.
Biotech loses a little Momentum (RSI) but holds near November Highs: IBB up 2.4% MTD; down 0.53% WTD; XBI down 0.51% MTD, down 1% WTD.
Frothy Genomics sector took a big hit with ARKG down 12.27% MTD, down 4.95% WTD, but still up 49% YTD; RSI fading to 38.
Healthcare stocks have been a good place to hide from the AI and IT volatility with good gains if you focused on the larger cap stocks. The easy way to play it was to start with well-known large cap biopharmaceuticals or The State Street Healthcare Select SPDR ETF (XLV), overweight with names like: Lilly, JNJ, Abbvie (ABBV), UNH and Merck. Even the IHI (iShares U.S. Medical Device) subsector caught a little momentum up 7.42% MTD before settling down flattish at $58 this past week. Medtech looks better with hospital utilization rates up but hindered by sporadic issues with internet security and hacking. Many of you who are only familiar with Biotech or Medtech should look more closely at XLV and IBB. For example looking at the heat map of the XLV we see winners MTD like CAH up 16.83% and MCK up 12.69%, and or HCA up 9.1%.

Admittedly it’s been hard tocus lately on healthcare stocks when the headlines are blasting headlines daily on AI and semiconductor stocks and the day-to-day volatility, especially when they represent up to 30% of your portfolio. Over the past ten years semiconductors have been a core play up over 11 % a year until the extreme volatility and momentum from AI stocks hit in 2026. For example, an overweight portfolio position in AMD this past month has a range of $400 to $650 settling on Friday at $534! Looking broadly across all subsectors over the past month through all the InfoTech turmoil (XLK) down 11.5%, Communication Services down 3.59%; the leaders were Healthcare (XLV) up 9.21%, Consumer Staples (XLP) up 7.88%, Consumer Discretionary up 7.29%. Other sectors that are impotent to note over the past month are Financials up 5.74%, Industrials flat up 0.175 and Energy down 2.55%. Materials were up 5.87% commensurate with inflation with the recent CPI of
The S&P 500 (SPY) at 754 is up 10.64% YTD, and has lost 2.62% over the past month, and RSI is flattish. A more important indicator of the market to track SMID Biotech is the Russell 2000 (IWM) at $277 near a six-month base of $270, is still up 12.75% despite lackluster performance this quarter down 8.72%. Many of the high-profile growth mid and small cap biotechs are included in the IWM. We focus on many of the stock in our SMID Biotech Focu List. trading model. During the recent Genomics sell-off here are several genomics stocks to watch for portfolio impact with MTD performance:
Personalis (PSNL) is up 90.64% YTD, now at $15.17 after being bought out by Tempus AI (TEM) for $1.5B.
Adaptive Biotech (ADPT) up 16%, Guardant Health (GH) down 7.75%, llumina (ILMN) down 23.4%.
As of 11:45 AM on 11/16 see is where we are: S&P 500 down 1.2%, QQQ down 1.82%, DIA down 0.77%, XLV flat at $189, SMH down 3.85, IBB down 0.9%, Russell 2000 (IWM) down 1.97%. ARKG is down 4.12% at $41.12.



Comments
Log in or sign up to join the conversation.